Ocaliva
These highlights do not include all the information needed to use OCALIVA safely and effectively. See full prescribing information for OCALIVA. OCALIVA (obeticholic acid) tablets, for oral use Initial U.S. Approval: 2016
cdfbe0cd-eb15-45a1-ac17-531bcda21aec
HUMAN PRESCRIPTION DRUG LABEL
Oct 18, 2022
Intercept Pharmaceuticals Inc
DUNS: 966658416
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Obeticholic Acid
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Obeticholic Acid
Product Details
FDA regulatory identification and product classification information